PGNY
USDProgyny Inc. Common Stock
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$18.280
Máximo
$18.840
Mínimo
$18.030
Volumen
0.61M
Fundamentos de la Empresa
Capitalización de Mercado
1.6B
Industria
Healthcare Plans
País
United States
Estadísticas de Negociación
Volumen Promedio
1.31M
Bolsa
NMS
Moneda
USD
Rango de 52 Semanas
Informe de Análisis de IA
Última actualización: 3 nov 2025PGNY Stock Analysis: What Progyny's Recent Moves Mean for Short-Term Traders
What's Happening With Progyny Right Now
Progyny (PGNY) is showing signs of exhaustion after a rough few months. The stock closed at $18.43 on November 3rd, down from $23 in early August--a nearly 20% slide over the past three months. The chart tells a clear story: persistent selling pressure with occasional spikes when news hits. Volume exploded to over 7.4 million shares on October 16th when the stock jumped 4.7% in one day, only to crash
Noticias Relacionadas
Progyny, Inc. Announces Details for Its Third Quarter 2025 Results Report
NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a global leader in women's health and family building solutions, will report its financial results for the quarterly period ended September 30,
Progyny Expands Global Benefits to Include Pregnancy, Postpartum, and Menopause
NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a global leader in women's health and family building solutions, today announced the launch of its pregnancy, postpartum, and menopause programs
Transcarent Experience Store Expansion: More Options for Women's Health
Maven Clinic, Midi Health, and Progyny provide support for menopause, perimenopause, and family building for Transcarent Members Easy access through WayFinding™ AI experience is a gamechanger Transcarent, the
Progyny CEO Named World Economic Forum Champion for Women's Health
NEW YORK, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a global leader in women's health and family building solutions, today announced that CEO Pete Anevski has been honored with the recognition as a
Predicción de IABeta
Recomendación de IA
Actualizado el: 4 nov 2025, 17:26
64.3% Confianza
Riesgo y Negociación
Punto de Entrada
$18.21
Toma de Ganancias
$19.66
Stop Loss
$16.58
Factores Clave
Acciones Relacionadas
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.